Showing results (81-90 of 521) with videos related to
Sort By:
Pageof 53
Current Opinion in Pulmonary Medicine|March 6, 2023
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdownDavid S C Hui, Alimuddin ZumlaClinical Reviews in Allergy & Immunology|April 12, 2007
High-content T-cell and B-cell analysisMarkus MaeurerThe Lancet. Infectious Diseases|April 3, 2016
Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkersRobert S Wallis, Markus Maeurer, Peter Mwaba, et al.BMC Medicine|July 2, 2016
Burden of respiratory tract infections at post mortem in Zambian childrenMatthew Bates, Aaron Shibemba, Victor Mudenda, et al.Infectious Disease Clinics of North America|November 1, 2019
Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and TreatmentSimon Tiberi, Alimuddin Zumla, Giovanni Battista MiglioriThe Lancet. Respiratory Medicine|March 17, 2015
Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapiesAlimuddin Zumla, Jeremiah Chakaya, Rosella Centis, et al.Nature Reviews. Drug Discovery|March 24, 2018
Accelerating the development of therapeutic strategies for drug-resistant tuberculosisMichael J Vjecha, Simon Tiberi, Alimuddin ZumlaNature Reviews. Drug Discovery|May 1, 2013
Advances in the development of new tuberculosis drugs and treatment regimensAlimuddin Zumla, Payam Nahid, Stewart T ColeInternational Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2015
Lessons for tuberculosis from scrutiny of HIV/AIDS and Malaria UK Parliamentary QuestionsMatt Oliver, Gillian M Craig, Alimuddin ZumlaCurrent Opinion in Pulmonary Medicine|April 28, 2009
Biomarkers for tuberculosis disease status and diagnosisMark Doherty, Robert S Wallis, Alimuddin Zumla, et al.Pageof 53